An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)
NCT04185363
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Progressive Familial Intrahepatic Cholestasis (PFIC)
Interventions
DRUG:
Maralixibat
Sponsor
Mirum Pharmaceuticals, Inc.